Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema
Public ClinicalTrials.gov record NCT04894110. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Prospective, Multi-Center, Open-Label, Dose-Escalation Study to Assess the Safety, and Tolerability of EO2002 with and Without Endothelial Brushing or Descemet Stripping in the Treatment of Corneal Edema (EMME-001)
Study identification
- NCT ID
- NCT04894110
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Emmecell
- Industry
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Interventions
- EO2002 Biological
- EO2002 high dose Biological
- EO2002 low dose Biological
- EO2002 mid dose Biological
Biological
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 21, 2021
- Primary completion
- Oct 2, 2024
- Completion
- Oct 2, 2024
- Last update posted
- Mar 4, 2025
2021 – 2024
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Los Angeles Location | Greater Los Angeles | California | 91208 | — |
| San Diego Location | San Diego | California | 92122 | — |
| Miami Location | Miami | Florida | 33136 | — |
| Palm Beach Gardens Location | Palm Beach Gardens | Florida | 33410 | — |
| Atlanta Location | Atlanta | Georgia | 30339 | — |
| Des Moines Location | Des Moines | Iowa | 50266 | — |
| Kansas City Location | Overland Park | Kansas | 66204 | — |
| Grand Rapids Location | Grand Rapids | Michigan | 49546 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04894110, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04894110 live on ClinicalTrials.gov.